Silver Book Fact

Increased use of a blood-thinning drug saves $600 million annually, because of the strokes it prevents.

Secondary and Tertiary Prevention of Stroke Patient Outcomes Research Team Final Report — Phase 1. AHRQ Web site. http://www.ahrq.gov/clinic/strokcln.htm. Published June 2000

Reference

Title
Secondary and Tertiary Prevention of Stroke Patient Outcomes Research Team Final Report — Phase 1
Publication
AHRQ
Publication Date
Published June 2000
Authors
Matchar D, Samsa G
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Effectiveness of treating ischemic strokert-PA within 3 hours of symptom onset
    A study of the  victims with effectiveness of treating ischemic strokert-PA within 3 hours of symptom onset showed a decrease in rehabilitation costs of $1.4 million and nursing home costs of…  
  • About 70% of the survival improvement in heart attack mortality resulted from changes in technology.  
  • The percentage of Americans age 55-64 with high cholesterol decreased between 1988-94 and 1999-2002, in part because of the increased awareness about the risks of high cholesterol and the increased…  
  • Eliminating out-of-pocket drug costs for combination pharmacotherapy for the 423,000 Americans with drug insurance who will experience their first myocardial infarction in 2006 would save 4,736 lives, and would save…  
  • Effectiveness of an oral pharmacologic agent in preventing venous thrombosis
    An oral pharmacologic agent has been demonstrated to be at least as effective as an injectable anticoagulant in the prevention of venous thrombosis following hip replacement.